VeriMomcannabis sativa flower extract은 임신 중 안전한가요?
No harmonised CLP reproductive classification for 'cannabis sativa flower extract' and no CIR or SCCS safety assessment identifying reproductive hazard for the botanical extract in cosmetic topical use. While systemic cannabinoids (e.g., Δ9‑THC) have reported reproductive effects in some studies, those refer to systemic exposure; topical cosmetic use of a botanical extract is expected to give negligible systemic exposure. Sources: ECHA Annex VI (no harmonised classification for this extract), CIR (no cosmetic safety assessment flag), PubMed (studies on systemic cannabinoid reproductive effects).
Pregnancy-safe products containing cannabis sativa flower extract
Related ingredients
Frequently asked questions
- cannabis sativa flower extract은 임신 중 안전한가요?
- No harmonised CLP reproductive classification for 'cannabis sativa flower extract' and no CIR or SCCS safety assessment identifying reproductive hazard for the botanical extract in cosmetic topical use. While systemic cannabinoids (e.g., Δ9‑THC) have reported reproductive effects in some studies, those refer to systemic exposure; topical cosmetic use of a botanical extract is expected to give negligible systemic exposure. Sources: ECHA Annex VI (no harmonised classification for this extract), CIR (no cosmetic safety assessment flag), PubMed (studies on systemic cannabinoid reproductive effects).
- cannabis sativa flower extract은 모유 수유 중 안전한가요?
- No authoritative classification or safety assessment (CIR/SCCS/ECHA harmonised) identifying breastfeeding-specific hazard for topical 'cannabis sativa flower extract'. Transfer to breast milk would require systemic absorption of cannabinoids; topical cosmetic use is expected to produce negligible maternal systemic levels. Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (systemic cannabinoid transfer studies noted but not applicable to low topical exposures).
- cannabis sativa flower extract은 아기 피부에 안전한가요?
- No evidence of intrinsic reproductive or developmental hazard of the botanical extract for infant topical use in authoritative sources. However, infant skin has higher per‑kg absorption and an immature barrier; if the extract contains measurable cannabinoids or other small lipophilic constituents there is potential for greater dermal uptake in 0–3 yr olds than adults. Therefore exposure score is increased by +1 (from adult negligible to low but measurable). Sources: CosIng (ingredient present in cosmetic inventories), general dermal absorption principles and PubMed literature on cannabinoid absorption (systemic effects relate to systemic exposure, not topical cosmetic use).
- VeriMom은 cannabis sativa flower extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 cannabis sativa flower extract을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 cannabis sativa flower extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.